BHP advances steel decarbonisation trials amid industry slowdown
BHP is advancing steel decarbonization trials with 13 global steelmakers, despite economic challenges. Projects include HyREX with POSCO and NeoSmelt in Australia, with trials showing progress in emissions reduction. BHP reported $24B in industry investment over the past year, but high costs and demand pressures persist.
How this was made
The 30-second read
Why it matters
The update frames decarbonisation as increasingly constrained by capital intensity, energy and hydrogen availability, and demand for lower-emissions steel, which can affect investor expectations for timing and returns on related projects.
Market read
Traders may treat this as a sentiment and risk update for BHP’s decarbonisation-related optionality, with timelines (2028-2029) and explicit economic headwinds.
What to watch
The article does not provide updated capex, funding commitments, or a final investment decision for NeoSmelt, so market reaction may be limited until those concrete financial milestones emerge.
Background
BHP is running multiple technology pathways to cut emissions from steelmaking, including hydrogen-based ironmaking (HyREX) and direct reduced iron plus electric smelting (NeoSmelt), alongside furnace and carbon capture trials.
Ticker impact
BHP reaffirmed progress on steel decarbonisation trials, including HyREX with POSCO and NeoSmelt in Australia, while flagging pressured project economics.
Likely modest pressure or volatility as investors weigh higher capital costs and weaker demand against continued trial milestones.
The article is a program update with multiple planned demonstrations (2028-2029) and explicit headwinds (capital costs, energy/hydrogen access, weaker lower-emissions steel demand), which can temper valuation expectations even without a new financial print.
Market effects
Highlights ongoing cost and infrastructure constraints for low-emissions steel, reinforcing a slower, multi-path technology adoption cycle across the steel value chain.
Australia-focused NeoSmelt design completion and planned commissioning keep attention on local DRI and smelting infrastructure timelines.
POSCO HyREX trial planning in South Korea underscores cross-border hydrogen-based ironmaking development despite weaker demand signals.
Counterpoint
Trial progress and partnerships could still attract future funding or policy support, making the near-term economics commentary less bearish than it sounds.
Key entities
- companyBHP
Miner and materials group running steel decarbonisation technology trials and partnerships.
- companyPOSCO
Steelmaker partnering with BHP on HyREX hydrogen-based ironmaking trials.
- companyBlueScope
Named joint venture partner on NeoSmelt in Australia.
- companyRio Tinto
Named joint venture partner on NeoSmelt in Australia.
- companyWoodside
Named joint venture partner on NeoSmelt in Australia.
